Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.

Endocrine-related cancer - 1 Mar 1999

Daidone M G, Luisi A, Veneroni S, Benini E, Silvestrini R

Abstract excerpt

Interest in translational studies aimed at investigating the role of biologic markers in predicting clinical outcome of breast cancer patients and, in particular, response to specific treatments, has progressively increased. Among biologic variables presently under investigation, apoptosis markers, in particular Bcl-2 and Bax expression, are receiving much attention for their relationship with the cellular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to bcl-2-Associated X Protein
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogens

Share to Genes, bcl-2

Share to Neoplasms, Hormone-Dependent

Share to Proto-Oncogene Proteins c-bcl-2

Share to Radiotherapy

Source

Identifiers

PMID: 10732789
DOI: 10.1677/erc.0.0060061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.PMID 10732789Read ↗

Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biologySemantic proximity Read ↗

Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.Semantic proximity Read ↗

Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.Semantic proximity Read ↗

Regulators of apoptosis in human breast cancer.Semantic proximity Read ↗

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.Semantic proximity Read ↗

REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIASemantic proximity Read ↗

Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.Semantic proximity Read ↗

Correlation between DNA double strand breaks and cell death in peripheral blood lymphocytes from breast cancer patientsSemantic proximity Read ↗

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.Semantic proximity Read ↗

Correlation between DNA double strand breaks and cell death in peripheral blood lymphocytes from breast cancer patients.Semantic proximity Read ↗

Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.Semantic proximity Read ↗

Up-regulation of Bcl-2 expression in cultured human lymphocytes after exposure to low doses of gamma radiationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.